Hostname: page-component-77c89778f8-gq7q9 Total loading time: 0 Render date: 2024-07-22T08:03:07.030Z Has data issue: false hasContentIssue false

P03-94 - Decision Aid For Antipsychotic Medication Choice

Published online by Cambridge University Press:  17 April 2020

L.A. Mistler
Affiliation:
Psychiatry, University of Massachusetts Medical School, Worcester, MA, USA
L.C. Curtis
Affiliation:
Advocates for Human Potential, Middlesex, VT, USA
I.H. Mahone
Affiliation:
School of Nursing, University of Virginia, Charlottesville, VA, USA

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Promoting client empowerment in mental health service and treatment is linked with positive outcomes and is considered an indicator of quality recovery-oriented services. However, most public mental health services do not yet fully implement this goal.

Aims

Recognizing that shared decision-making (SDM) technologies have the potential to encourage more effective communication and collaboration, SAMHSA and Advocates for Human Potential are developing SDM resources for public mental health services and the people they serve.

Objectives

We report on field tests of one resource, a decision aid (DA) for consumers considering use of antipsychotic medication.

Methods

After conducting a literature review and analysis of decision support materials, we performed consumer and provider needs assessments to guide DA development. We constructed a 7-module Webbased consumer-centered DA that follows IPDAS standards. We tested the prototype with groups of consumers and providers available to the team.

Results

Responses to the DA have been mixed. Some providers are concerned about “sharing” treatment decisions with clients and feel there is too much information in the DA. Some consumers want more information yet feel the DA is too long. Both groups express enthusiasm about the use of a DA for antipsychotic medication.

Conclusions

Adapting SDM concepts and tools to public mental health settings has unique challenges. Traditional assumptions about competency of people with mental health diagnoses have resulted in a history of provider-dominated decision-making. While DAs are designed to help balance power in the clinical encounter, we recognize that there are more obstacles to overcome.

Type
Psychotic disorders / Schizophrenia
Copyright
Copyright © European Psychiatric Association 2010
Submit a response

Comments

No Comments have been published for this article.